{
  "thread": {
    "uuid": "7582c5deb075589efe654ef580d957137537dce6",
    "url": "https://finance.sina.com.cn/money/fund/aiassistant/zcgyd/2026-01-15/doc-inhhkmpr7575746.shtml?cref=cj",
    "site_full": "finance.sina.com.cn",
    "site": "sina.com.cn",
    "site_section": "https://finance.sina.cn/?from=redirect",
    "site_categories": [
      "tech",
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news",
      "politics",
      "science and technology",
      "economy, business and finance"
    ],
    "section_title": "新浪财经_金融信息服务商",
    "site_title": "æ°æµªè´¢ç»_éèä¿¡æ¯æå¡å",
    "title": "益方生物股价跌5.1%，长城基金旗下5只基金重仓，合计持有805.88万股浮亏损失1305.53万元|基金重仓_新浪财经_新浪网",
    "title_full": "益方生物股价跌5.1%，长城基金旗下5只基金重仓，合计持有805.88万股浮亏损失1305.53万元|基金重仓_新浪财经_新浪网",
    "published": "2026-01-15T07:59:00.000+02:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "CN",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 548,
    "domain_rank_updated": "2026-01-11T23:00:00.000+02:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "7582c5deb075589efe654ef580d957137537dce6",
  "url": "https://finance.sina.com.cn/money/fund/aiassistant/zcgyd/2026-01-15/doc-inhhkmpr7575746.shtml?cref=cj",
  "ord_in_thread": 0,
  "author": "小浪财讯",
  "published": "2026-01-15T07:59:00.000+02:00",
  "title": "益方生物股价跌5.1%，长城基金旗下5只基金重仓，合计持有805.88万股浮亏损失1305.53万元|基金重仓_新浪财经_新浪网",
  "text": "1月15日， 益方生物 跌5.1%，截至发稿，报30.12元/股，成交3.36亿元，换手率2.60%，总市值174.20亿元。\n资料显示，益方生物科技(上海)股份有限公司位于中国(上海)自由贸易试验区李冰路67弄4号210室,香港湾仔皇后大道东183号合和中心46楼，成立日期2013年1月11日，上市日期2022年7月25日，公司主营业务涉及创新药物的研发、生产和销售。主营业务收入构成为：技术授权和技术合作收入100.00%。\n从基金十大重仓股角度\n数据显示，长城基金旗下5只基金重仓益方生物股票，合计持有益方生物805.88万股，按前一日收盘31.74元，今日截止发稿股价30.12元计算，日浮亏1305.53万元。\n基金名称 基金代码 基金经理 持股数量(股) 占流通股比例(%) 占基金净值比(%) 持股数量变动(股) 长城医药产业精选混合发起式A 022286 梁福睿 4733992 1.1335 8.23 +1839568 长城医药科技六个月混合A 011673 谭小兵 1132781 0.2712 7.45 +43633 长城大健康混合A 013037 谭小兵 854505 0.2046 7.89 -413996 长城医疗保健混合A 000339 谭小兵 739721 -- 7.62 -168528 长城健康生活混合A 008786 谭小兵 597850 0.1431 4.44 新进\n其中，长城医药产业精选混合发起式A（022286）三季度增持183.96万股，持有股数473.4万股，占基金净值比例为8.23%，位居第四大重仓股。根据测算，今日浮亏损失约766.91万元。\n长城医药科技六个月混合A（011673）三季度增持4.36万股，持有股数113.28万股，占基金净值比例为7.45%，位居第七大重仓股。根据测算，今日浮亏损失约183.51万元。\n长城大健康混合A（013037）三季度减持41.4万股，持有股数85.45万股，占基金净值比例为7.89%，位居第四大重仓股。根据测算，今日浮亏损失约138.43万元。\n风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建议。\nMACD金叉信号形成，这些股涨势不错！",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "chinese",
  "sentiment": "negative",
  "categories": [
    "Economy, Business and Finance"
  ],
  "topics": [
    "Economy, Business and Finance->business reporting and performance",
    "Economy, Business and Finance->business and market analysis",
    "Economy, Business and Finance->financial and economic news"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": true,
  "webz_reporter": false,
  "external_links": [
    "https://finance.sina.cn/app/sfa_macd.shtml?source=pccj",
    "https://www.finance.sina.cn/app/sfa_macd.shtml?source=pccj",
    "https://finance.sina.cn/app/sfa_macd.shtml"
  ],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": null,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news"
    ],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2026-01-15T08:05:52.245+02:00",
  "updated": "2026-01-16T09:12:38.000+02:00"
}